Guardant Health
GH
#1779
Rank
ยฃ9.03 B
Marketcap
ยฃ69.60
Share price
-4.15%
Change (1 day)
108.24%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -ยฃ2.45

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.38. In 2024 the company made an earnings per share (EPS) of -ยฃ2.64 an increase over its 2023 EPS that were of -ยฃ3.17.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.45-7.3%
2024-ยฃ2.64-16.82%
2023-ยฃ3.17-33.13%
2022-ยฃ4.7460%
2021-ยฃ2.9655.04%
2020-ยฃ1.91207.14%
2019-ยฃ0.62-19.81%
2018-ยฃ0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ2.05-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.59-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA